GlassScriptPhysician profile
Qun Gao
NPI 1538330964
$1,696.95
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $462 · 2021: $552 · 2022: $70.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $871.10 | 2019-2022 | |
| Gilead Sciences, INC. | $194.39 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.78 | 2019-2021 | |
| Pfizer INC. | $102.09 | 2019-2020 | |
| Braintree Laboratories, INC. | $86.11 | 2019-2021 | |
| Janssen Biotech, INC. | $83.58 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.17 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $36.67 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $31.65 | 2019-2020 | |
| Daiichi Sankyo INC. | $21.60 | 2021 | |
| Shire North American Group INC | $16.89 | 2019 | |
| Celgene Corporation | $16.77 | 2021 | |
| Redhill Biopharma INC. | $15.61 | 2021 | |
| Boston Scientific Corporation | $14.96 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.68 | 2019 | |
| Qol Medical, LLC | $13.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qun Gao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.